A new study by researchers at the Hutchinson Institute for Cancer Outcomes Research at Fred Hutchinson Cancer Research Center and the University of Washington has found that 20 percent of cancer clinical trials fail to draw enough participants to render verdicts on experimental therapies.

Visit link:
Study identifies several risk factors linked to low patient-accrual rates in cancer clinical trials

Scroll to Top